Seeking Alpha
 

Zimmer Biomet Holdings, Inc. (ZBH)

- NYSE
  • Apr. 24, 2014, 12:46 PM
    | Comment!
  • Apr. 24, 2014, 9:28 AM
    | 1 Comment
  • Apr. 24, 2014, 7:21 AM
    • Zimmer (ZMH) has agreed to Biomet for $13.35B in cash and stock, with the deal including debt.
    • Zimmer shares are +6.3%. (PR)
    | Comment!
  • Feb. 26, 2014, 9:43 AM
    • Anika Therapeutics (ANIK) surges 41% to $48.67 following the FDA's approval of the company's Monovisc single injection for pain caused by osteoarthritis of the knee.
    • The authorization must feel pretty sweet for Anika - it first applied for approval over four years ago.
    • Summer Street has hiked its price target to $60 a share from a prior PT of $47.
    • "We believe this product will be competitive in a market that is becoming more focused on single-shot injections," Summer Street says.
    • There are 27M people in the U.S. who suffer from osteoarthritis, which occurs when cartilage breaks down in joints, causing pain and stiffness as bones rub together.
    • Sanofi (SNY +0.1%) and Zimmer (ZMH +0.4%) sell rival products.
    | Comment!
  • Jul. 10, 2013, 2:19 PM
    Zimmer Holdings (ZMH +1%) gains today after saying that it's begun distributing its APEX Spine System, a set of implants and instruments designed to correct a broad range of spinal deformities as well as complex and degenerative spinal diseases. Under the terms of a long-term agreement with SpineCraft, Zimmer Spine will exclusively market the APEX Spine System to healthcare organizations across the U.S., Canada, Australia and New Zealand.
    | Comment!
  • Apr. 5, 2013, 4:00 PM
    Zimmer Holdings (ZMH -1.9%) slips today as Credit Suisse cuts their estimates on the company's Q1 and its reiterated Neutral on the shares. The firm says that it's at the high-end of guidance range, and U.S. knee/hip market growth needs to be more carefully watched. The company lowers its 2013/2014/2015 EPS estimates to $5.74/$6.24/$6.83, from $5.76/$6.30/$6.92 respectively.
    | Comment!
  • Jan. 30, 2013, 1:28 PM
    Zimmer Holdings (ZMH -1%) slips on a downgrade to Hold at Summer Street on valuation. The stock has been on a tear since the beginning of the year, rising nearly 17% on optimism over FDA clearance to market iASSIST Knee for knee replacement procedures.
    | Comment!
  • Apr. 26, 2012, 9:20 AM
    Premarket gainers: PATK +26%. HTWR +15%. REGN +14%. NUAN +14%. LOGI +14%. VHC +12%. CTXS +12%. NRGY +10%. EQIX +9%. CRUS +8%. SPPI +8%. INCY +7%. XLNX +7%. WPI +7%. AMRN +5%. EA +7%. MWW +5%. AH +6%. PHM +6%. AIS +5%. AIXG +5%. LSI +4%. TS +3%. UN +3%. ZNGA +3%. FRO +3%. RDS +3%.
    Losers: FURX -28%. PCS -15%. HRB -15%. TQNT -14%. ALU -13%. TSPT -12%. AET -9%. PTX -7%. AKAM -6%. AZN -6%. ZMH -5%. DB -5%. HERO -5%. STD -5%. DOW -4%. CELG -4%. CS -4%. CROX -4%. GG -3%. BWA -3%. UNH -3%. LVS -3%. VALE -3%. UPS -3%. POT -3%.
    | Comment!
  • Dec. 20, 2011, 9:05 AM
    Premarket gainers: CSIQ +27%. PGNX +26%. AIS +17%. SLXP +11%. S +7%. CLWR +7%. JEF +6%. ALU +6%. NOK +5%. DB +5%. RIO +5%. MT +4%. STD +4%. BBVA +4%. STM +4%. VHC +4%. GSS +4%. ANR +4%. MS +4%. ERIC +4%. BHP +3%. ZMH +3%. VALE +3%. ITUB +3%. SNE +3%. C +3%. VE +3%. X +3%. MU +3%. HAL +3%. SI +3%.
    Losers: TRGT -22%. RHT -8%. GFA -4%.
    | Comment!
Visit Seeking Alpha's
ZBH vs. ETF Alternatives
Company Description
Zimmer Biomet Holdings Incis engaged in designing, manufacturing & marketing orthopaedic reconstructive products; sports medicine, biologics, extremities & trauma products; spine, bone healing, craniomaxillofacial & thoracic products &dental implants.